Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

Conditions

• Gastric Cancer Peritoneal Metastases

Interventions

• DRUG: albumin-bound paclitaxel (260 mg/m2, d1)
• DRUG: S-1
• DRUG: sintilimab
• DRUG: bevacizumab

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology